C.R.S. Section 12-280-108
Powers and duties

  • rules

(1)

The board shall:

(a)

Intentionally left blank —Ed.

(I)

Inspect, or direct inspectors who are licensed pharmacists to inspect, all outlets and investigate violations of this article 280.

(II)

The board’s authority under this subsection (1)(a) to inspect all outlets includes the authority, after conducting a risk-based assessment, as defined by the board by rule, to inspect an out-of-state pharmacy, a nonresident 503B outsourcing facility, or an out-of-state wholesaler.

(b)

Prescribe forms and receive applications for licensure, certification, and registration and grant, renew, reactivate, and reinstate licenses, certifications, and registrations;

(c)

Deny, suspend, or revoke licenses, certifications, or registrations;

(d)

Apply to the courts for and obtain restraining orders and injunctions in accordance with section 12-20-406 to enjoin violations of the laws that the board is empowered to enforce;

(e)

Administer examinations to, and determine the qualifications and fitness of, applicants for licensure, certification, or registration;

(f)

Keep a record of:

(I)

All licenses, certifications, registrations, and license, certification, and registration renewals, reactivations, and reinstatements for a reasonable period;

(II)

All suspensions, revocations, and any other disciplinary actions; and

(III)

Its own proceedings;

(g)

Collect all fees prescribed by this article 280 and section 12-20-105;

(h)

Fine registrants when consistent with the provisions of this article 280 and the rules adopted pursuant to this article 280;

(i)

Conduct investigations, hold hearings, and take evidence in all matters relating to the exercise and performance of the powers and duties of the board in accordance with section 12-20-403;

(j)

Review and approve or reject applications for participation in the pharmacy peer health assistance program pursuant to part 2 of this article 280 and perform any other functions that were performed by the rehabilitation evaluation committee prior to its repeal;

(k)

Send a quarterly electronic newsletter to all licensees by e-mail that details changes in state law that affect or are pertinent to the practice of pharmacy.

(2)

The board has other duties, powers, and authority as may be necessary to enforce this article 280 and the rules adopted pursuant to this article 280.

(3)

The board may:

(a)

Adopt a seal to be used only in the manner the board prescribes;

(b)

Promulgate rules governing the compounding of pharmaceutical products, which rules must address the following:

(I)

Training and qualifications;

(II)

Quality control;

(III)

Internal operating procedures;

(IV)

Procurement of compounding materials;

(V)

Formulation, documentation, and testing requirements;

(VI)

Equipment standards;

(VII)

Facility standards; and

(VIII)

A recall system.
(4)(a)(I) Whenever a duly authorized agent of the board finds or has probable cause to believe that, in any registered outlet, any drug, nonprescription drug, or device is adulterated or misbranded within the meaning of the “Colorado Food and Drug Act”, part 4 of article 5 of title 25, the agent shall affix to the article a tag or other appropriate marking giving notice:

(A)

That the article is, or is suspected of being, adulterated or misbranded;

(B)

That the article has been detained or embargoed; and

(C)

Warning all persons not to remove or dispose of the article by sale or otherwise until the board, its agent, or the court gives provision for removal or disposal.

(II)

No person shall remove or dispose of an embargoed article by sale or otherwise without the permission of the board or its agent or, after summary proceedings have been instituted, without permission from the court.

(b)

If the board or the court removes the embargo, neither the board nor the state is liable for damages because of the embargo if the court finds that there was probable cause for the embargo.

(c)

When an agent finds that an article detained or embargoed under subsection (4)(a) of this section is adulterated or misbranded, the agent shall petition the judge of the district court in whose jurisdiction the article is detained or embargoed for an order for condemnation of the article. When the agent finds that an article so detained or embargoed is not adulterated or misbranded, he or she shall remove the tag or other marking.

(d)

Intentionally left blank —Ed.

(I)

If the court finds that a detained or embargoed article is adulterated or misbranded, except as provided in subsection (4)(d)(II) of this section, the court shall order the article, after entry of the decree, to be destroyed at the expense of the owner of the article under the supervision of the agent. The owner of the article or the owner’s agent shall bear all court costs and fees, storage, and other proper expense.

(II)

When the owner can correct the adulteration or misbranding by proper labeling or processing of the article, after entry of the decree and after the owner has paid the costs, fees, and expenses and has posted a good and sufficient bond, conditioned that the article be properly labeled or processed, the court may direct, by order, that the article be delivered to the owner for proper labeling or processing under the supervision of an agent. The owner shall pay the expense of the agent’s supervision. The bond must be returned to the owner of the article once the board represents to the court that the article is no longer in violation of the embargo and that the owner has paid the expenses of supervision.

(e)

It is the duty of the attorney general or the district attorney to whom the board reports any violation of this subsection (4) to institute appropriate proceedings in the proper courts without delay and to prosecute the matter in the manner required by law. Nothing in this subsection (4)(e) requires the board to report violations when the board believes the public interest will be adequately served in the circumstances by a suitable written notice or warning.

Source: Section 12-280-108 — Powers and duties - rules, https://leg.­colorado.­gov/sites/default/files/images/olls/crs2023-title-12.­pdf (accessed Oct. 20, 2023).

12‑280‑101
Public interest - rules
12‑280‑102
Applicability of common provisions
12‑280‑103
Definitions - rules
12‑280‑104
State board of pharmacy - creation - subject to review - repeal of parts
12‑280‑105
Membership of board - removal - compensation - meetings
12‑280‑106
Veterinary pharmaceutical advisory committee - creation - appointments - rules - repeal
12‑280‑107
Rules
12‑280‑108
Powers and duties - rules
12‑280‑109
Drugs, devices, and other materials
12‑280‑110
Publications
12‑280‑111
Malpractice claims information - not public - exception
12‑280‑112
Fees
12‑280‑113
Approval of schools
12‑280‑114
Licensure, certification, or registration - applicability - applications - licensure and certification requirements - rules
12‑280‑115
Exemptions from licensure - hospital residency programs - home renal dialysis - research companies
12‑280‑115.5
Certification of pharmacy technicians - requirements - provisional certification - criminal history record check - rules
12‑280‑116
Expiration and renewal of licenses, certifications, or registrations
12‑280‑117
Continuing education - exceptions - inactive status
12‑280‑117.5
Continuing education for pharmacy technicians - exceptions - inactive status
12‑280‑118
Prescription drug outlet under charge of pharmacist - rules
12‑280‑119
Registration of facilities - rules
12‑280‑120
Compounding - dispensing - sale of drugs and devices - rules - definition
12‑280‑121
Compounding drugs for office use by a veterinarian - rules - definitions
12‑280‑122
Limited authority to delegate activities constituting practice of pharmacy to pharmacy interns or pharmacy technicians
12‑280‑123
Prescription required - exception - dispensing opiate antagonists - selling nonprescription syringes and needles
12‑280‑124
Labeling - rules
12‑280‑125
Substitution of prescribed drugs and biological products authorized - when - conditions
12‑280‑125.3
Pharmacists’ authority - minor prescription adaptions
12‑280‑125.5
Pharmacists’ authority to dispense chronic maintenance drugs - rules - liability
12‑280‑125.7
Pharmacists’ authority to prescribe and dispense HIV prevention drugs - definitions - rules
12‑280‑126
Unprofessional conduct - grounds for discipline
12‑280‑127
Disciplinary actions
12‑280‑128
Judicial review
12‑280‑129
Unlawful acts - civil fines
12‑280‑130
Unauthorized practice - penalties
12‑280‑131
New drugs - when sales permissible
12‑280‑132
Advertising of prescription drug prices
12‑280‑133
Nonresident prescription drug outlet - registration
12‑280‑133.5
Nonresident 503B outsourcing facility - registration - requirements - denial, revocation, or suspension - rules
12‑280‑133.7
Third-party logistics providers - registration - denial, revocation, or suspension - rules
12‑280‑134
Records
12‑280‑135
Unused medication - licensed facilities - correctional facilities - reuse - definitions - rules
12‑280‑136
Confidential agreement to limit practice
12‑280‑137
Investigations of suspicious drugs
12‑280‑138
Patient counseling - pharmacists required to perform - patient may decline - rules
12‑280‑139
Insulin affordability program - record keeping - reimbursement - definitions
12‑280‑140
Emergency prescription insulin supply - eligibility - record keeping
12‑280‑141
Prescription drugs - automated pharmacy dispensing system - rules - definition
12‑280‑142
Epinephrine auto-injector affordability program - record keeping - reimbursement - definitions
12‑280‑201
Legislative declaration
12‑280‑202
Definitions
12‑280‑203
Pharmacy peer health assistance fund - rules
12‑280‑204
Eligibility - participants
12‑280‑205
Liability
12‑280‑206
Immunity
12‑280‑301
Definitions
12‑280‑303
Wholesaler registration requirements - rules
12‑280‑304
Record check
12‑280‑305
Restrictions on transactions
12‑280‑306
Records - pedigree - compliance with DQSA
12‑280‑307
Penalty
12‑280‑308
Manufacturer, agent, representative, or employee - drug cost information - required - definitions
12‑280‑401
Legislative declaration
12‑280‑402
Definitions
12‑280‑403
Prescription drug use monitoring program - registration required - applications - rules - appropriation - repeal
12‑280‑404
Program operation - access - rules - definitions
12‑280‑405
Prescription drug monitoring fund - creation - fee
12‑280‑406
Violations - penalties
12‑280‑407
Prescription drug outlets - prescribers - responsibilities - liability
12‑280‑408
Exemption - waiver
12‑280‑409
Examination and analysis of prescription drug monitoring program - recommendations to executive director
12‑280‑501
Written guidelines and procedures for making therapeutic interchange and therapeutically equivalent selections
12‑280‑502
Therapeutic interchange and therapeutically equivalent selections for nursing care facility or long-term acute care hospital patients - rules
12‑280‑601
Definitions
12‑280‑602
Collaborative pharmacy practice agreements - pharmacist requirements
12‑280‑603
Rules
Green check means up to date. Up to date

Current through Fall 2024

§ 12-280-108’s source at colorado​.gov